Impact of next-generation sequencing on clinical outcomes in advanced EGFR-mutant lung cancer patients after resistance to osimertinib.

被引：0
|
作者：
Cheng, Jia-Tao
Yang, Jin-Ji
Wu, Yi-Long
机构：
[1] Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20726
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients
    Vered Fuchs
    Waleed Kian
    Rachel Lichtenberg
    Jonah M. Cooper
    Areen A. Remilah
    Daniel Levin
    Nir Peled
    Laila C. Roisman
    [J]. Clinical Drug Investigation, 2022, 42 : 185 - 192
  • [32] An exploration of the clinical progression models of osimertinib in the treatment of advanced EGFR-mutant non-small cell lung cancer
    Shi, Yue
    Jiang, Yingying
    Pan, Banzhou
    Wang, Zihan
    Li, Hang
    Ma, Yuxin
    Liu, Yilin
    He, Kang
    Wang, Zhitong
    Lu, Jianwei
    Shi, Meiqi
    Shen, Bo
    Zhou, Guoren
    Yin, Rong
    Rossi, Antonio
    Ito, Kentaro
    Santarpia, Mariacarmela
    Um, Sang-Won
    Wang, Xiaohua
    Chen, Cheng
    Feng, Jifeng
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 817 - 831
  • [33] Treatment Patterns and Clinical Outcomes in Patients with EGFR-mutant NSCLC after Progression on First-Line Osimertinib
    Robinson, N. D.
    Zhan, P.
    Udelsman, B.
    Boffa, D. J.
    Goldberg, S. B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S364 - S364
  • [34] Biomarker Testing for Advanced Lung Cancer by Next-Generation Sequencing in Elderly Patients
    Basbus, L.
    Minatta, J. N.
    Ferreira, Y.
    Antivero, A.
    Pandolfi, J.
    Garcia Rivello, H.
    Dalurzo, M.
    Lupinacci, L.
    Jauk, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1035 - S1035
  • [35] Concurrent genetic alterations identified by next-generation sequencing in pre-treatment metastatic EGFR-mutant lung cancers.
    Yu, Helena Alexandra
    Jordan, Emmet
    Feldman, Ai Nit Daniel
    Rodriguez, Christopher
    Kim, Hyunjae Ryan
    Kris, Mark G.
    Solit, David B.
    Berger, Michael F.
    Ladanyi, Marc
    Arcila, Maria E.
    Riely, Gregory J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Responder of Gefitinib Plus Crizotinib in Osimertinib Failure EGFR-mutant NSCLC-Resistant With Newly Identified STRN-ALK by Next-Generation Sequencing
    Zhou, Chunhua
    Zeng, Liang
    Zhang, Yongchang
    Yang, Nong
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (07) : E143 - E144
  • [37] Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
    Chiang, Chi-Lu
    Ho, Hsiang-Ling
    Yeh, Yi-Chen
    Lee, Cheng-Chia
    Huang, Hsu-Ching
    Shen, Chia-, I
    Luo, Yung-Hung
    Chen, Yuh-Min
    Chiu, Chao-Hua
    Chou, Teh-Ying
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (01) : 5 - 14
  • [38] Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
    Chi-Lu Chiang
    Hsiang-Ling Ho
    Yi-Chen Yeh
    Cheng-Chia Lee
    Hsu-Ching Huang
    Chia-I Shen
    Yung-Hung Luo
    Yuh-Min Chen
    Chao-Hua Chiu
    Teh-Ying Chou
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5 - 14
  • [39] Comprehensive Next-Generation Sequencing Guided Targeted Therapies Improve Clinical Outcomes of Lung Cancer Patients
    Wang, Z.
    Zhu, D.
    Lu, B.
    Liu, G.
    Xu, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S704 - S704
  • [40] Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
    Oxnard, Geoffrey R.
    Paweletz, Cloud P.
    Kuang, Yanan
    Mach, Stacy L.
    O'Connell, Allison
    Messineo, Melissa M.
    Luke, Jason J.
    Butaney, Mohit
    Kirschmeier, Paul
    Jackman, David M.
    Janne, Pasi A.
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (06) : 1698 - 1705
12345